DXCM - Earnings call transcript Q4 2019

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Welcome to the Dexcom Fourth Quarter 2019 Earnings Release Conference Call. My name is Cheryl, and I will be your operator for today's call. [Operator Instructions]. Please note that this conference call is being recorded. I will now turn the call over to Sean Christensen. begin. may you Sir,

Sean Christensen

and Earnings DexCom's Call. operator, full Quarter Year XXXX welcome you, fourth to and Thank

of Corporate full Our Steve update Chairman, financial COO who President summary and President Vice begins review Pacelli, and quarter Development. agenda with Quentin Strategy then of CEO, our will Kevin and outlook CFO, provide Executive Blackford, by and XXXX, from followed year Sayer, from Dexcom's the and a and our a strategic a

will open At participating we provide the Dexcom the call fourth up ask Following to are questions. remarks, website our for Relations to today. Investor can the for your that our there quarter page. so also that analysts performance everyone and prepared note an events on presentations opportunity we we slides on time, Please to X available limit themselves question related

With our that, let's review harbor statement. safe

made today's These detailed and or Some such date future any forward-looking and law, actual are Commission. and make differ forward-looking from the no to presentation will Except XX-K the to statements. assume to constitute of products, expressed to uncertainties operating forward-looking The forward-looking as update in with various statements by of performance. actual Dexcom's on statements and the these beliefs results after of Exchange could differ intentions, required to statements materially from based Securities on may date those management's factors by plans the All statements. statements statements the expectations results. these conform strategies, actual filings cause reflect that competition, or we included and call as forward-looking this are implied annual presentation other in events, any Form in obligation report information are we about currently risks this in and could results subject those hereof anticipated available materially DexCom, of forward-looking statements

measures otherwise as considered results. financial a are prepared GAAP. this discuss be results GAAP in should call, the to quarter earnings and refer tables prepared to cash-based in to a metrics references to fourth during non-GAAP earnings accordance year with comparable isolation reconciliation GAAP the all our the measures or respect will financial that superior with The substitute to for Unless in accordance been or noted, have not information slides measure. for presentation directly on basis. additional and in Additionally, of presentation certain we of these Please results presented financial not our non-GAAP a release and with accompanying full most the our

to Now I will turn it over Kevin.

Kevin Sayer

our XXXX This Thank more year million, that in a that perspective, we given of that turn you, we everyone, year. this another to and we added started us. means $X joining of want for thank our than a our this consecutive million take on some growth organic exceeded the was accomplishments you, year DexCom. base into greater XX%. revenue was than before few the second minutes year growth put for absolute the I highlight to $XXX Sean, fantastic XXXX. to attention To

to in New Medicare. the to in patients market, insulin-dependent traction type continue the the driver addition and we where existing coverage includes growth be our to behind primary continue X access growing expand in

And globally, We they are product. are reminder, who patient CGM ended from a as a XXX,XXX we only the approaching patients consistently as count technology. benefiting year Dexcom's when reordering someone net active

full profitability. with discipline history operational and growth organization. GAAP year represented was most We spending achieving as are the an and XXXX Dexcom's profitable first year this also in our of

as even R&D future continue capacity to drive XXXX invest in to demonstrating operating doubled our in great GX leverage are growth. We we and

more patients. to U.S., by the we meaningfully building are covered than we progress we our to to making more great are and as our In in As expanded channel in XX% transition grow, the we pharmacy adapting lives serve effort infrastructure XXXX.

and to forward fingerstick to patients NOL access We are the GX those in fully launch now underway GX of technology. having into look the Medicare

built We global services extensive in service exiting our Manila of on with in XXXX, progress year an key have business team customer metrics. all the

Our business our company possible continue as us a services to scale best will great offer team be asset experience. the the strive to customers we for and

with and transparent our you we also about improve. are things customers the We must

care shareholders in and health heard share greatly system told ability family server temporary do you that providers of ones I customers. we in a many our via since, to of experienced and loved improve outage of impacted communication a do significant we weeks that. needed glucose the our We better. follow to and with levels taken to late apps. the As friends our November, to customers, that just In needed have steps we place monitor

real-time have on functionality, updates on week. days of system schedule. provides launched X status day, a XX We ahead system a hours This a our page website

in We an of with system final quick in-app that the our are also communication messaging customers. provide rolling will stages out

are experienced of even reason The for GX. we the growth with this is since see, not rapid sitting launch can still, you simple. the As that we've

there We believe opportunity that us of still for huge a our platform. ahead is sensor

fingersticks for issues in our to the address CGM potential remain our of excitement from as we global of to markets, the underlying continues core Outside Dexcom's CGM of standard our grow. confident to the care. broader markets, core For shift health

early stage for are of diabetes, X the beginning demonstrating on type all CGM those not insulin great data therapy. value including see to with people We

use population CGM forward XXXX. to Our work expanded type in progressed very Group with has X we UnitedHealth Dexcom's in their and well, of look the

CGM all coaching to DexCom with like continue platforms. with directly players partnerships into through offered the digital presence by WellDoc, to their we data will health type additional of programs look work respective And Livongo for providers. CGM X Onduo, and We extend customers integrating

those to like relative revealed CGM details forward we with and to cost Dexcom fingersticks. of XXXX. discussed an look pilot year in other as additional We per related work conference gross Healthcare, markets nearly providing at X using savings using for using new progress Intermountain these type recently X we type to $X,XXX As investor those initial for our member per non-insulin customers

With driven biggest our markets, launch all in this GX an the in with ongoing and eye learnings growth toward enter new Dexcom's history, we our core in of product markets XXXX GX.

have in to a launch great far goal team We of us a busy toward ahead, a but has the for our done year job full-scale thus XXXX. progress

Dexcom, summarize, many in long-term another pressing for but to forward on execute capitalize great these XXXX XXXX To we're and was year opportunities.

review Quentin will I call a for of financials. turn now to over our the

Quentin Blackford

Kevin. Thank you,

presented unless on to discussed As today's in IR be a financial today GAAP a basis. reminder, Reconciliations can earnings non-GAAP as release be otherwise well noted, will our metrics website. on the found as

revenue of currency million million quarter the basis. fourth $XXX of For compared to the of reported we reported of fourth quarter and for both $XXX.X on worldwide representing XXXX, constant the XXXX, XX% growth

of the As business. represented difficult reminder, comp for both of quarter fourth worldwide year and a XXXX most U.S. entire the for the our XXXX

our primary New the to value driver our people remains patients of CGM. continue as growth gain of the adopting technology DexCom awareness of

and satisfaction access. As type are customer traction continue growth that push new increased we volumes Throughout patient Kevin market these XXXX, population, the X with patient this pleased we've our noted, fueling GX strong to increasing to where among momentum. includes for steady see been

quarter growth our continued Despite comp XXXX. of the to most the with fourth in difficult very U.S. well, XXXX, XX% of business quarterly grow in growth

revenue than growth lower accompanies indicates, transition patient As channel. the to offsetting initiatives revenue our volume that pharmacy our are our per the more

our DME all year, in Similar of growing growth our We response of quarter Medicare, we with pharmacy months GX U.S. channels the saw expectations. of is in growth awareness XXXX. our growth The XX% the CGM and the saw to business to launch great currency of to came the business. this compared driving well, what the performance from X exceeded as international expanding first in fourth as from has quarter strong our fourth constant

growth excellent board. markets very like Germany direct across our distributor the see to and continue U.K. and also growing markets the with strength We are well in

the e-commerce the our launched results time we're in note, for history, of more the first saw the with we as in company's nearly Canada number doubled patients, quarter. we Of than and fourth in new our pleased platform

gross XXXX. XX.X% quarter to of Our million profit XX.X% compared quarter in revenue revenue $XXX.X fourth of of was fourth the or

we in line was our quarter in highest margin gross XX.X% expectations the for significant margin the our year-over-year a saw represented the on in improvement anticipated, call. The with sequential the step-up point As quarter noted since XXXX. third

efforts on improve to to cost Our manufacturing, our access teams focus us compromising without product efficient and automated margin. reduced meaningfully increase giving designing channels incremental prioritize in flexibility continue gross patient improvements that and

to cost the receive offset scale design, our year-over-year and for This XXXX. the we Operating XXXX $XXX.X into XXX XX% compared lines. were head to certain expenses new full the GX, revenue reflects we from in As transmitter and the fourth Medicare GX helps customer XXXX. GX manufacturing up $XXX.X which will QX such cost million million GX items benefit as from XXXX a of of an in base GX as and quarter increase QX percentage transition point of of basis a

fourth the launch was primarily driven toward efforts in incremental related spend growth our R&D advance to GX quarter expense The plans. we as by our

or the in significantly year, on full XX% compared to quarter $XX.X operating long-term fourth income operating growth, as or growth million of for invested XXXX. same a opportunity. well of even Dexcom's total XX% improvement $XXX.X This quarter revenue below Operating in of revenue the margin year-over-year basis the of XXXX growth expenses capitalize the million For remained to in our we quarter. was reflects revenue the of in points XXX XX.X% XX.X%

the quarter $XX.X or XX.X% of EBITDA XXXX. revenue Adjusted revenue XX.X% of fourth or for fourth to the for $XXX.X million quarter was compared of million

EBITDA quarter, quarter our came XX.X% on the the XX.X% respectively, margin X% full ahead strength of of year as revised guidance the and adjusted Given provided third operating margin year of full of of our and in well XX.X%, call. fourth

we cash share. numbers we full both markets. position with in the explore also manufacturing equivalents cash the or in than on history, that million new billion in our opportunistically GAAP exhibiting leverage these a full XXXX organization. We we as balance the established quarter our scale and GX Net support, profitability our GX remain CGM year an GAAP in $X.XX the remain as As and was in first fourth discipline exit strong income $X.X In But as our of year year. the for income confident and continue XXXX, of for net cash we greater real-time first and will also $XXX.X with invest to of we're million. the $XXX.X potential sheet per use for company's of time we

continues growth Given allocation the supports that us, opportunity. are of organic be to capital priority opportunities ahead that our growth our

guidance. XXXX to Turning

of integrated average many of GX that anticipate $X,XXX,XXX,XXX, month, like same as including we stated This CGM contemplates continue we as higher XXXX, patient market. are reduction last the of annual and considerations and we launch of year factors offset systems growth XX%. that Medicare As to of well the expanded and our of full new in awareness we lower to representing environment. channels grow, access as per competitive to These a continued volume revenues the populations come navigated between XX% tailwinds rate prices growth navigate DexCom realization a $X,XXX,XXX,XXX as of Dexcom by revenue to in with surrounding towards growth

to margins. Turning

toward Investor We our at continue track our well long-term Day. established to targets XXXX

guidance that States. in up costs identifying margin site manufacturing our manufacturing third are will associated type and as reside of of anticipate XX%, plan and of patient well as growth market to in to we third This the centers. technology Included in site patients beginning outside value our Diego gross begin set our with we beyond a United cost to to must are better early production efforts San our adoption international improving for of validation that support products, expectations of approximately reduce base that following Mason stages gross further our we XXs. technology, mid- of non-GAAP the the our in and invest patient For realizing support our our our and X the the expansion will margins gross the core strategy margin results: our remain long-term XXXX, given overall

to our shared center global to investments increasing continued which in increase the efforts. of DTC in We the by our benefits expect approximately and operating margins contemplates XX%, Philippines, services GX offset

adjusted that to expand XX%. expect will Finally, we approximately margins EBITDA

expenditures first in invest the with saw will expand to manufacturing the our in of of of you can capital XXXX. what United and in scale-up the As of the capacity States, outside double imagine, footprint our year, ambition GX excess in XXXX require GX half we

for With that, now the call will to I update. turn over a Steve strategic

Steven Pacelli

Quentin. Thanks,

the with the game As our course enabling with results look in doubling very with plan we XXXX capacity these GX achieved We expansion geographies forward expand half and in has XXXX throughout year Customer that for more double satisfaction the GX first GX us marketing. to XXXX. from with ramp new and into diabetes we of again to than in the people and as to our benefits high, been of markets and GX remains before XXXX our XXXX launched. existing the to indicated, capacity continuing a revenue changer markets launch direct-to-consumer well new of XXXX, our efforts as was

We are way its now to years GX, than have still a and of X.X full the launch potential. into long realize go more to we

forward platform the As Canada in our to we of mentioned, launch rollout markets XXXX. great and expanding has of platform additional throughout Quintin success a this look e-commerce been to the

and have GX long GX, are thrilled it base Medicare customers We complete waited to expect of by be to mid-XXXX. them. to a our transition for Many these of we time the providing to

the to as to Medicare well access as soon GX patients from who many stand possible. as As benefit more

We for South look market this Korea will access continue later and Japan year. to like of to in the forward and markets expanded GX push introduction

and to us insulin. job in great position on type for payer market pharmacy up efforts X access, done type diabetes XXXX, with to open both teams momentum their continued including people and a X Our have access for

on transition base positioned progress we've reminder, XXXX, But we the our are in the overnight, doing DME and the made insulin the delivery very to through pharmacy. are this In meaningful our began position We're excited drive trial, later the in customer have believe of integrated in covered year. in the be customer progress December, lives which systems will happen we with contemplated transitioning in a the pivotal launch make a the Horizon about to remain Dexcom not for We're for that to even multiple in integrated Insulet XXXX. system. well As we to they excited we Insulet guidance. process in pharmacy track with work

forward with Our system agreement pen December GX, in will bringing commercial and Eli initially was in a on step offering. another focus signed smart officially Lilly their market with represents which to

launched DexCom X integrated system, GX automated based boluses In automated type the the offering, and their pump latest January, correction This Control-IQ the to system first incorporating sensor insulin integrated algorithm offer is Tandem delivery. our to overnight, our in do of that the kind designation These obtained iCGM customer an off simply the algorithm. controller. achievements we brand because are ACE ratings or an regulatory the CGM AP of I not happen pump

goes relationship to effort hard our mentioned the I multiple the of each integrate takes systems In remains fact, significant with innovative companies delivery the that technologies in with to Dexcom insulin and and It just to leader the diabetes CGM work years. back community. time bring

much performance we into fully towards nickel. the GX, that is larger a are love of turning with result. CGM we moving is GX, that And a believe going success Even the disposable ongoing only to the our slightly are of DexCom GX. real-time product customers attention than With of

affirmed line GX for today in time we rollout XXXX. a mentioned, our full Kevin As

GX we that launch market expect potential has to numbers GX states We far are size focused which has for disease the our in we of the of serve. which we are the to belief and we have we opportunity on outset, for CGM, we of for the been clinical much the that to currently scale to address designed think support From GX, the than larger customers be continue for than currently initiating mentioned. ran and greater real-time trial, scale-up lines time trial manufacturing GX support the to

development head the the into to markets of strategy new expansion our opportunities, product existing to our as new market XXXX. ongoing Dexcom focused geographies is into development and we of CGM From

pass that, Kevin. it With I will back to

Kevin Sayer

to Thank momentum. ever of this that the excited you, XXXX of opportunity and there momentum, year a but for scenes Steve. well call about a continued on as Last ensure XXXX talked ahead year, lies was XXXX the as year behind Dexcom positioned. I with that very a lot entering was of spoke and work We're milestones. as

of since and of how CGM and to expand launch day position in are Dexcom's channels efficient customers. additional each on GX focused the to our about the use right growth are learning best for We inventory the

would Sean? I Q&A. open to for the call up now like

Sean Christensen

Thank you, Kevin.

audience limit and we reminder, necessary. time this the a at to question As Q&A then X ask the to themselves our instructions. queue if please provide only reenter Operator,

Operator

[Operator Instructions].

first comes Baird. from question Our from Jeff Johnson

Jeffrey Johnson

Congratulations on you the okay? hear year. me Can

Kevin Sayer

absolutely. you, can We hear

Jeffrey Johnson

year of of about commercial X this a love Great. to on maybe the how maybe I would competitive my formulary help Kevin, mix love with with lot you thoughts with the gains? this could right. And that but how feel All sensor think year, of adds go, seen question, specifically, we've changes volumes Would at to the new U.S. I share let guess, focus start you business. your hear me of MDI year? the might versus hear some places this patient maybe

Kevin Sayer

a That's question. X complicated pretty

those grown. the a can. pretty new So adds a delivery. are to pens of adds, majority as to grow a number way new who was injection our expand Do with of deal and well, patient respect quickly the pump as year, I patient of using best still as control there have but new we've significant to With who our their daily multiple are patient expanded insulin to insulin patients, patients adds, I'll and the as this We math. majority we've

getting daily on patients injections. multiple to have be We

pleased that up of now. good a that for that here. we on On access formulary that will of just see respect year couple was front. see With next picking we think the very new great increased all we right with year things growth the patients we're coming, the be our number a to and the around It very the front, in we're competitive insulin patient using there's

The intensive then under really that first and up all will increased be increased of patients. type our on and many the is That insulin a are plans to starting more many access us, of pharmacy for opens for good X open doors And there. plans, the guidelines of Medicare lot coverage.

easy our pharmacy how our has store While better over accessible here, to since is That been and not be better. drug going is to and there. we the the been product to utilization over we we and has as rollout can get better to and see do business retention to get trying But best. learn the make choppy we're higher, We'll that as a core started. more bit again, learn

So all strong those for things point XXXX very a to us.

Operator

next comes Jayson from Raymond question Our Bedford James. from

Jayson Bedford

I'll ask an uncomplicated question.

In I'm not here but call, of approved the terms and in expectation GX part of I you your timing is XXXX? that sure it -- missed get

Kevin Sayer

that but is it And full-scale our expectation believing goals limited We filing learned a Our in those this that in we scaled rollout objectives, XXXX. about up GX. and lessons still get our GX need reviewed, happen with apply the is and to we manufacturing spoken in we've trial that's XXXX. X don't going several times in we to to want the XXXX, and of done, launch launch and and anybody primary

the So focus to we everybody want our that XXXX. is launch focus in big and focus on

time share talk as information, commercialization line, can As we line it. more or about today. now. we can trial time share, on. that's giving lines get that's filing more and any we for not time go We that our really we'll We're our But

Operator

America. Bank Our of comes Travis Steed from from question next

Travis Steed

year. a great Great. Congratulations on

So a Quentin. for I question had

coming lot you And You've looks did got end margins for conservative up now before. a potentially XX% by than year. achieve goals revenues than this year, it on XXXX, could this operating if better of that which more

XX% have be can operating pharmacy margins that that? Is business. So a term, long-term business scale. structurally profitability this GX you Or to just GX would this manage And anything business about there inhibiting gross back? you would think about from to where there to long anything more additionally, that the Is there through channel, margin? at being as at XX% trying the step is is launching anything of

Quentin Blackford

guidance. margin out basis trying had at the away in in When time, did if never to Yes. we towards, a the draw that the we was It's that operating reference that, was could mind. we were end just navigate were thought time. lines put It that out point an good a the XX% we At in where goal along you could were progress but points question. confident we we point it more that we And we recall, was we from in that make. when of X,XXX future

considerably to investment anticipated. structurally We're ready point, go to closed us us. more that expectations won't your of beyond of than not that to business revise faster We bullish kind can this XX%. nothing these quite go. gap new we've allow of in front the be So excited But we about what those the there's the couldn't we markets long-term and in are where opportunities even in

You hospital, sure international opportunities to us think to the gestational, to of non-intensive all being that we're going to beyond then And up, make able that in XX%. the incredible we're none sure them but to the we going these investing keep on of expansion, the that open into is that time. get about Xs, make type from things are

nothing there's no, us whatsoever. concerns structurally So that

the able would even profile get with to to. go idea produce GX, the low-cost That that from it where you. was been And was far cost product a in very very able be GX, mind. remind that to I beginning to will designed just we've below at

in complements all in So need from lower-priced way that compete need if be to of channels greater a the my perspective, aggressive we're opportunity marketplace to. all trying it But even the profitability achieve to up is to to that in profile volumes open long-term that here. to, does we we push

trying we're do. what to complementary to very think, I So

Operator

next from JPMorgan. from Marcus Robbie Our comes question

Robert Marcus

nice of see you guidance right years Maybe meaningfully would place and what congrats versus walked two versus exceeded XXXX. volume remember in year? could just be. mix to We Quinton, the help the start range. and we've year, really year. is And a I similar echo over kind initial you your on price us us you've looked if the quarter this something I'll last And why then understand through past off

maybe the versus U.S. in do the range? could helpful. and would really break guidance what's be That you down assumed If same international? And

Quentin Blackford

Sure.

So the to a today. from core that bullish the in just very we markets of on revenue us perspective, we sits in opportunity front continue be that in participate

how to adoption which ahead very in lot It's come the we're or quickly of on in hard convince leaves there different to technology, the we're know profiles and in a technology it runway. think ourselves they the takes we early of But predict, long and patient very adoption also to I respect. them. that how get cycle not going of to that are

we price a in if that contemplated $XXX That's I continue guidance be numbers million million clear dollar contemplated way we about our think patient there. an $XXX you perspective, we've in it over guidance, look from about headwinds out assumes per that walk average put XXXX. thought very And down are as in at million year-over-year. there to increase revenue is that to time been our the guidance absolute we is the $XXX

So to back increase on million apples-to-apples to prior gross if that add to, to million guided the revenue $XXX increase increase. an takes about the year net that basis $XXX you versus we've that

guidance we wrapped your did start in I a You think mind XXXX we've just to the around compare increase that of provided. get $XXX and to what million that you

guidance at in point think time. And this feel It of we've opportunity. in we about got like ahead appropriately. good feel there's it. sense doesn't incredible out to ourselves So We make get

Operator

William from Blair. from question Margaret comes Kaczor next Our

Malgorzata Kaczor

several of I have some so of including on. guys the and JPMorgan updates wanted elaborate to have at because you been last the little first, on Maybe a bit months the some had lot, data over and a that partnerships there

of more talked some to So pipeline how the that material Kevin, should how especially partnerships this think really becoming should in you activity. the about think those more on, timing beyond really, we And commercial year, big. there thinking Are about we those? about

Steven Pacelli

I Yes. this I to you think look Steve. mean, -- is have

and Basal-IQ to both intensive Tandem hopefully, don't And of core and Control-IQ in point lines, into this later speak insulin launching think U.S. year. you Horizon Tandem need our I time kind the I and to some business, their Europe got this but want bifurcate for year. OUS, launching of on we've hopefully, kind at later Control-IQ with currently partnerships

already folks So contributors, are there already our these are there all near-term certainly be go right? new or those systems. of these many But they are them some on will revenue Dexcom a are launches. are as are patients as who patients on those product patient result Because of meaningful -- going incremental probably portion additions

that the market the JPMorgan the JPMorgan. kind of kind JPMorgan. about talked that is frame year, X the that on this some early non-intensive around in of follow really about follow was So the up, product, strategy, really but trying making type we're side at we're we're savings of early update is work launched we're We really The working doing showed non-insulin we cost talked that those we are goal concrete out up. the with fully Between payer that mean, really still we're right? data I we ago progress and opportunity Intermountain, first With business but stage. with way with evidence That's exciting. Lilly, with opportunity particularly time the United, period We still some using of before the this new X real definitely stage, to year the some there. here, space. that, Margaret, with. partnerships that a systems there's the to of The a

there. significant that from but be business. huge out-years the The outside there's going excited type using about think to 'XX, as think not a So there's core thinking revenue business, And opportunity data start kind you 'XX, and of certainly I in of businesses I XXXX look contribution insulin about revenue wouldn't much X really it. contribution a intensive from to meaningful our 'XX, we're super a more I non-insulin -- supporting that

Operator

from Blicker comes Ryan from question next Cowen. Our

Ryan Blicker

the that installed XXXX You talked how contributions patient intensely to either is just big base additions? that overall, growing you quantify now new XXXX? for new And anything or about patient as the from X patient expect you on do strong then and managed of a population adds type in us front, grow Is proportion can there population. versus

Kevin Sayer

patients take number Yes, patient types I'll think type it's is X peds, We this the a a don't patient this now. break give everybody the for We stratify out of to in right Kevin. good won't start. those things that. year and did everybody I between really place base. Medicare We

Second of don't get it? Yes, you question. part why

Steven Pacelli

think not it. I but to slows probably if continues a bit, the to number absolute think up comparable, rate be about growth slightly, the way the is

Operator

Danielle comes question from SVB next from Antalfy Our Leerink.

Danielle Antalffy

on congrats of which year. we be need specifically think color go through and to give QX, to moving you at on we Any really as there anything cadence I as be helpful seasonality think about usually QX about a Is would fantastic is how year. to quarterly look Quentin, cognizant yes, just a the can I weak wanted the quarter. into seasonally ask on we And modeling.

Steven Pacelli

go. Sure,

full about XXXX, to I historic probably to QX it. street the seen seasonality where the XX% think would this that think is think close have at point of the the I about in right year generally seen we that. currently time, feel has good modeled that way business in represent we've We've

about got that to dialed continues channel, bit, seasonality XXXX. mature, as in overall seasonality. the pharmacy get the not you begin well may have a you to think, time, bigger So I pretty a business, Medicare part but to more terms in as of flowing revenue thinking you're probably as do in continues represent through of how change guys I to think the business over

it, probably are and I is think historic way good model. right a way to the about to trends think XX% roughly

Operator

Stanley. question Morgan Lewis Our from David from comes next

David Lewis

higher the on upside think the for revenue XXXX the look and likely 'XX at be kind and the that sort dialed right incremental to to is to rate? way of are year, incremental expenses about that year a little if implied upside just Is there's fall for guidance reflects guidance. implied look down at of XXXX quick, in 'XX 'XX, to this just the is I that your at I OP a going to leverage a -- expense. for relative versus if leverage the follow-up dollars the mean lower, revenue One

Quentin Blackford

Yes.

how see continue the business. months, I to in in basis X,XXX points we'll in OpEx very driven the to David, you'll business. think XX of So manage this about point, disciplined be your we've we last leverage what is

very support discipline steward has also 'XX, example, resources, front poured in see to significant in the never for on opportunities spend some a really that fuel team DTC thought might the really So We we create. commercial the been we we a perspective it we have channel fire to accountable, sitting the up investment capacity the the perspective into, some how us but demand really business. manufacturing that open pour in thoughtful, and our didn't from of from

XXXX, our We is and meaningful will up a that way in in in contemplated open DTC spend.

we we're and on drive around guided, to like As particularly these of it sure kind and sure drives going passing the let beyond incremental how market we for up through. flow I for think what the be population your want it that would make efforts, that cost future. that into success But to revenue, caring patients. things set can that not we opportunities And we'd make in that then how learning knowing we're margin. we it DTC, We're that drives take non-intensive around we out new of I if thoughtful the investment think to very disciplined point, would about yes,

investing that's on margin So revenue outperforms, we're at. perform the us you'll then I think well where If front. see

Operator

question Kyle next from comes Rose from Our Canaccord.

Kyle Rose

gestational bit wanted week's quarter. just but to a you you like those at on opportunities. when we It also Steve, how hospital strong the of non-intensive opportunities some the about year XXXX next Day, kind little think you should about Analyst out gestational on potential model data looks ATTD, at of understand use beyond? X in type the be broke flowing use. Congrats talked there will and start of But a like opportunities through some

Steven Pacelli

Yes.

done. about So There's of done. if work being being -- there's you're specifically certainly outside type asking Xs, opportunities research non-insulin there's non-intensive, using

side, us. to that X non-intensive basically the the lowest type going fruit hanging done kind You're we've of on would some be of next see for as kind we've cascade. preliminary clinical What work logical a recognized

hospital after with you're close So to where first see second. being go us that's probably a what going --

offices bit limited gestational, that. terms like more of things it's a an the but OB\GYN's like said, touch in of In market, and little exciting you terms into points

to those that's a incremental and say, would certainly and all hospital some well. our you're several what there's on So of next initiatives as need over there the for in years -- we're going working cascade of categories. pregnancy strategy We update labeling But increasing for there. underway see I contribution to a

Operator

from next Matthew Jaffray. comes O'Brien Our from question Piper

Matthew O'Brien

non-intensive that a Sandler. want But X on bit little to actually just to Kevin It's would love ask a the will question Piper follow-up But I I'm more sure commentary. hate. multipart type

secondly, patients. group frame of kind a traditional non-intensive of don't ones, type access up you're level? or without for not reimbursement? group? you million First that Is there. group There's kind if X.X And signaling Steve about you're the about slowdown But not. concern opportunity thinking of your intensive all, that I you X.X it's this in And know that around then level million managed of if MDI can any some

Kevin Sayer

market Kevin. both And strategy, to there. that we hold U.S. pillars And that as will in again, care geographies, in do And our in of range of other penetration becomes of to take the said business grow is as at room continue I believe serve than years, I here can a and the in not still basis first I grow. less of down. And combined possible. is think look our plenty going the XX% to slow a to much number here, is and in With to our CGM a standard base We XX% certainly to that CGM those. continue is U.S. that all there I've on penetration for XX% This intensive to patient fact,

of intensive the business, we automated get plenty systems there's as out market. So more on particularly grow room integrated to the in

X respect Type business. non-intensive to With the

sure XX Now of people hundreds U.S. a X.X talking the we've benefit million it's make and a X.X space. And people, closing and little address I'll my the of more learned, that tremendous bit thanks, question. we in tremendous, in comments going we're maximize million world. we're But million we're to good that talking we not millions of can around that but CGM people to a believe the has there. things

Operator

Blackman from from Stifel. Our comes next question Matthew

Mathew Blackman

XXXX. you out investment Quentin, in called an DTC priority

So then dollars? can the talk on about DTC do magnitude returns in typically And you you of quickly those how returns see you revenues? manifesting investment get

Quentin Blackford

Yes.

of see year. DTC in to really on back us start the half turn the you'll spend So

XXXX double a where the from exited get we goal is perspective part to to by capacity we mid time Our of XXXX. the

that in real will of what It's the benefit part business, not we to can best capacity disclose you built going monitor going mid the the tell some of supply of typically, like start X tangible It's enough demand of that any back double Once turn up So DTC it's company. there, the to are we And months returns make. a see investment the rate will to see investments in once from we in could efforts. the we couple that might We on that any come that can feel year. X terms by the I we've of to we part. again very something but is, we it's but highest exactly you, it the closely. make handle I'm take results into in back

Operator

from next Our question comes Denhoy from Jefferies. Raj

Rajbir Denhoy

of there roughly absorbing into the the price points. actually absorbing do I impact settles that like that guess, another not year? you're where about XX When which Is offset to normalized Is talked $XXX that every due of out? a I of at we're point year, point coming more points XXXX, perhaps would XX and price imagine it you sensor? question a you're mix this sounds that it's channel level experiencing. of have million, the the mix you a mix kind

Steven Pacelli

Yes. we've X more that year. price And walk our again Well, is walk ago. down, We has have started volume time out incredibly to down it demonstrated, played what that and really over down price walked offset strategy I to last we think Raj, well. than years

probably a set going a to. or we'll will years, into offset And to this well. a compete feel market there's that fact up price I point volume great more feel at consider we'll at to good that this couple that incredibly be being we're we're those price But the then we're point GX You're in point. more get to we've than when you per trying very continue to from. point that And the but that we feel it, think revenue impact got X patient feel that XXXX mind price We bringing of like year.

we'll a incredible a then offset but couple sustainable continue here that there's being with point So more into we're have we it. than through And probably navigate years think GX. it, at where of quite to the an product is volume future

Operator

Capital. question next Our from comes Berenberg Robbie with Marcus

Unidentified Analyst

Can you hear me okay?

Kevin Sayer

Yes.

Unidentified Analyst

behind more than little question just the that transmitter Quarter on the Can new a a expected. bit item -- or reorders starts? Just through just had of patient on walk strong. little was us what we reason that pretty line on bit a so you revenue, strength it's there terms in

Steven Pacelli

the an easier a was out there numbers you at just the perspective, on that look bit will think to I up patient was a new of line from transmitter if than I point it in comp the strength the fact quarter. show fourth the of continue the Yes, on there see sensor there. comp you line

go distinct continue drove can our that bit sitting of and that. as It sure each through as keep of ago and think on X we transmitter up mind, a So revenue, back an look account that bit continue strategy comp of into position the ourselves in units year if of having where would revenue product, impact GX. GX to sensor and how in for transmitter as a -- versus to contemplate X the different sensor pricing I in very an easily you which the that step there account buckets. was those in a evolve a versus way that is a we X the form factor, ends we unit you very in just little then a we at company make easier transpiring And growth. on

right of But into we model buckets future. through upon new the revenue is we to strategies. an now accounting it. way make just the contemplate that to continue want to how based giving nuance little that to you seeing that have pricing is We allocate to you're and we're something and going a we're what So right business bit like about revenue these sure think the the report

Operator

Our next question comes from Steven Lichtman from Oppenheimer.

Steven Lichtman

international, it's been lot very On there's and a been of there. obviously, strong, breadth

the Japan a I side think, of is the you year, have on you that mentioned you what launched is the bit Japan. countries, little talk ahead, looking As just later more ahead? in personnel Steve, you'll look Can and X when you this opportunity about think

Kevin Sayer

Yes.

is GX is -- of So the extent in this use first have to of to approved product. we unknown, in personal that reimbursement kind year. -- get whether the you if will, for and half big CGM a the hope big what The still

if comes or in it the If That's cycle. this next year it after. So come great. not, could year

U.S. like markets, in our instigated is of of all growth, -- by So I would you the reimbursement. really tell that outside growth

But Japan the So pay in little not it's cash in you the always we're going know, approach we taking certainly launch get product there. wait as a easy. a world, bit And we're as approval. once to and of see

say the So updates for wait on you're what reimbursement looking front is really on Japan I'd for.

Operator

question BTIG. And our comes from from final Marie Thibault

Marie Thibault

to And wanted about I little details manufacturing on milestones be we margin what for up. line? hear XXXX as third throughout it plans impacts or the your looking site, more wrap should cadence for the I'll a it bit gross OUS.

Kevin Sayer

Sure.

going a we in a you're sits end probably strategic that of really focus taking have we move effort the while of I ultimately So business. that excited And cost let well, us our price that very identifying that and time, there is and overall our put on lower stages about a see lot very us of in market. where the more but international business, in XX% be think to as that of of manufacturing the can will a opportunity. the also core gets opportunity front closer the environment. advantage locations of capability production compete user We over up to We're sub part, us early reduce couldn't much standing in

sense. So strategically, tremendous it a amount makes of

step more as select out know over be multiple start talk we stand exactly what supply. of year work these for course we facilities, get now we no years San got capacity start facility producing mesa couple where we and that settle to to capability. that to build out impact a us things about that we're won't the it our to of is years hear right we've take on up. once that we the ensure have and to ensure that to But here. full But Diego the on ready You'll of international in that We in into opportunity the

that we're don't business, So we us. of getting can ahead hold do ensuring it, up what it we're the for about and excited

Operator

time, session. concludes comments. closing to the I to Kevin that At turn back for question-and-answer Sayer this And over call would like our

Kevin Sayer

thanks, of for We around here world week, participating and all San a our much, accomplish a wanted the leaders in had very leadership you to summit. Diego for the today. of company things. of Thank everybody, Last couple we

work. had. celebrate we do hard. that We wanted And did but all we their thing to year first call to want universal And like growth an amazing I that thank for team is the today this for The the group. have like did year, is is this hard people on we XXXX amazing around our

we'll there out our expect our we what do to do what wanted and intensively technology offer great our continue plans similar investor That the we to future, markets, we have for on type And to to the X a to thing diabetes. intend alternative how best and core we managed second conferences. patients our we for focus this with move group. then our applications The to and is and care lay leave never will other in

X from a people, that you the got long diabetes left intensive summit, wondering is DexCom, months to reaffirm AXc was Great the X tell note on children, committed X, I about business. first after control. leaving we patients, After things management woman this if report child above AXc not have had to to an their As she oftentimes, why what that's summit who what her on young and provider -- down ever side, of she the could what said get and a you we XX. expecting would our and we're child. she afraid, happen of to she because was is because outcome, And

people often following X them past CGM? X had the On the as wearing the to community, a should be They weeks, time. a and the the thing with conversations answers wearing numerous looked type asked hear diabetes X should all about and and we of Because in this be question. me both side, Type in couple the time. physicians I've with of all my said go at surprise, we How

Hence, company the about it. hence, figure continue grow need We and and in thanks, than hence, to You we the facility, more a our we to on another commercial for we on out to business and today, continue to do expand, side. and way are R&D everybody, invest side couldn't listening. be bullish our

Operator

you, does call. This conclude conference today's for participation. Thank and And gentlemen. ladies thank you your

now may You disconnect.

DexCom (DXCM) 13 Feb 202019 Q4 Earnings call transcript